Awards

/Awards
Awards 2018-06-13T17:00:57+00:00

Vay Liang & Frisca Go Award for Lifetime Achievement

RODGER A. LIDDLE, MD

Dr. Liddle received his undergraduate degree from the University of Utah and medical degree from Vanderbilt University. He performed his internship and residency in Medicine at the University of California, San Francisco (UCSF). He was a fellow in Gastroenterology at UCSF where he also performed his postdoctoral research training in the laboratory of John A. Williams (former APA president and Go Lifetime Achievement Awardee). Dr. Liddle has served on the faculties of UCSF and Duke University and is currently Professor of Medicine at Duke University Medical Center.

At Duke, Dr. Liddle has held numerous leadership positions, including Chief of the Gastroenterology Division at Duke University Medical Center. He has also served as Chief of Gastroenterology and Associate Chief of Medicine at the Durham VA Medical Center. Dr. Liddle is an internationally recognized investigator in the physiology of the gastrointestinal tract and pancreas and has had continuous NIH research funding for over 30 years. He is a member of Alpha Omega Alpha, the American Society for Clinical Investigation and the Association of American Physicians. Dr. Liddle is author of over 200 peer reviewed scientific articles and book chapters. Dr. Liddle’s laboratory focuses on the regulation of gastrointestinal hormones, pancreatic physiology, and experimental models of pancreatitis.

While in the laboratory of John Williams, Dr. Liddle established a reliable bioassay for measuring blood levels of cholecystokinin (CCK). Consequently, he was able to ascertain the physiologic actions of CCK in animals and humans. This work led to studies on pancreatic physiology and experimental models of pancreatitis. Since then he has led programs on the role of trypsin and trypsin inhibitors in the pathogenesis of pancreatitis, the role of neurogenic influences on pancreatic inflammation, and the role of mechanically sensitive ion channels in the pancreas to explain how pressure causes pancreatitis.

Dr. Liddle has served on numerous NIH and VA study sections, national professional committees and editorial boards. He was Associate Editor of Gastroenterology (2001-2006), Senior Associate Editor of the American Journal of Physiology (2009-2012), Associate Editor of the Journal of Clinical Investigation (2012-2017) and is currently Associate Editor of JCI Insight. He has chaired the Pancreatic Section of the AGA Council and most importantly served as president of the American Pancreatic Association in 2012.

Dr. Liddle owes his investigative career to the mentorship and guidance of John Williams, whose laboratory embodied scientific rigor and enthusiasm for pancreatic investigation. Out of John’s laboratory came many colleagues whose careers have also been devoted to the pancreas; including past APA presidents Murray Korc and Craig Logsdon.

Dr. Liddle has been supported throughout his career by his wife and family. He and Joanne have been blessed with three lovely children, Emily, Sloane, and Patrick, and (as of this writing) five wonderful grandchildren.

Past Recipients

  • 2016: CHRIS E. FORSMARK, MD
  • 2015: STEPHEN PANDOL, MD
  • 2014: WILLIAM CHEY, MD AND ASHOK SALUJA, PHD
  • 2013: MICHAEL STEER, MD AND MASAO TANAKA, MD, PHD
  • 2012: HORST F. KERN, MD AND MURRAY KORC, MD
  • 2011: ANDREW L. WARSHAW, MD
  • 2010: PETER A. BANKS, MD

Distinguished Service Award

JULIE FLESHMAN, JD, MBA
President and CEO, Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is a nonprofit, 501(c)(3) nationwide network of people dedicated to fighting the world’s toughest cancer. Founded by a group of pancreatic cancer survivors and caregivers in 1999, the organization relentlessly pursues its mission by implementing an aggressive and comprehensive strategy of research, patient support, advocacy and awareness. The Pancreatic Cancer Action Network is headquartered in Manhattan Beach, Calif., and also staffs a Washington, D.C. and New York City office.

Julie Fleshman became the organization’s first full-time staff person and its first Executive Director in April 2000. Having lost her father to pancreatic cancer in 1999, she has made it her passion and commitment to change the course of the disease. In July 2004, the Board of Directors appointed Fleshman President and CEO. Under her leadership, the Pancreatic Cancer Action Network has grown from a staff of one with revenues of $228,000 to a staff of over 140 with a budget of more than $38 million.

Today, Fleshman is a sought-after speaker with considerable experience addressing diverse stakeholder groups, including Congress, industry, patients, scientists, donors and volunteers. She has also been interviewed by national media such as The New York Times, CNN, Headline News and ABC News as well as local press throughout the country.

Fleshman has spearheaded the charge to ensure the Pancreatic Cancer Action Network achieves its goal to double pancreatic cancer survival by 2020. Her leadership has driven consistent excellence and innovation throughout the programs and services of the organization, including introducing precision medicine service Know Your Tumor® and Precision PromiseSM, the first large-scale adaptive clinical trial for pancreatic cancer. At the same time, she has steadily increased revenue growth and the organization’s impact. Under her direction, the organization has greatly expanded and attracted leading researchers from prestigious institutions around the country to study pancreatic cancer.

During Fleshman’s tenure, advocacy and grassroots efforts have expanded to over 60 affiliates nationwide and yielded a $100 million increase in federal funding for pancreatic cancer research. The organization has awarded 159 pancreatic cancer research grants totaling over $40 million to researchers at institutions around the country. And more than 165,000 pancreatic cancer patients and their families nationwide have been served by the organization’s patient services program.

Fleshman holds her JD and MBA degrees from Santa Clara University and a BA from the University of California, Santa Barbara, where she graduated Magna Cum Laude. She also studied abroad at Oxford University and in Tokyo, Japan. Fleshman has been honored for her leadership and dedication in the fight against pancreatic cancer by many organizations. She serves on the boards of several cancer care and research committees and organizations, recently completing her term as a patient advocate on the National Cancer Institute’s Pancreas Task Force, and she has been published in multiple research journals. Most recently, she was asked to join the FasterCures Patients Count Leadership Council and to serve on the NCI Council of Research Advocates to provide advice to the NCI Director with respect to promoting research outcomes that are in the best interest of cancer patients. In addition, Fleshman is the Chair of the World Pancreatic Cancer Coalition, a coalition of more than 60 pancreatic cancer organizations representing 27 countries around the globe.

Past Recipients

  • 2016: SUDHIR SRIVASTAVA, PH.D., MPH, MS
  • 2015: MUSHTAQ KHAN, DVM, PHD
  • 2015: JOSE SERRANO, MD, PHD
  • 2014: STEPHEN P. JAMES, MD
  • 2013: AGI HIRSHBERG
  • 2012: EDWARD D. PURICH, PHD

Hirshberg Award

Each year, the Hirshberg Foundation gives an award to the best abstracts in pancreatic cancer presented at the Annual Meeting. In 2016, the awards went to:

BEST CLINICAL SCIENCE ABSTRACT
AATUR SINGHI – UNIVERSITY OF PITTSBURGH MEDICAL CENTER

Each year, the Hirshberg Foundation gives an award to the best abstracts in pancreatic cancer presented at the Annual Meeting. In 2016, the awards went to:

BEST BASIC/EXPERIMENTAL ABSTRACT
THOMAS MACE – THE OHIO STATE UNIVERSITY

Il-6 And Pd-l1 Antibody Blockade Combination Therapy Limits Tumor Progression In Murine Models Of Pancreatic Cancer

NPF Award

Each year, the National Pancreas Foundation gives an award to the best basic science and clinical abstracts in pancreatitis. In 2016, the awards went to:

OLGA MARENINOVA – UNIVERSITY OF CALIFORNIA LOS ANGELES

Downregulation of Atg4b Stimulates Autophagy and Ameliorates Alcohol-induced Pancreatic Injury

SANDRA VAN BRUNSCHOT – ACADEMIC MEDICAL CENTER

Endoscopic or Surgical Step-up Approach for Necrotizing Pancreatitis, A Multi-center Randomized Controlled Trial

Presidential Award for Best Basic Science Abstract

With the large number of basic science abstracts submitted this year, we wanted to also recognize the exceptional work done in this category. At the 2016 meeting, the award went to:

KRUTIKA PATEL – MAYO CLINIC

Bile Acids(BA) in Human Pancreatic Necrosis(PN) Worsen Acute Pancreatitis(AP) via a Non-micellar Interaction With Fatty Acids(FA).